Wednesday, July 8, 2026

Patent intelligence · US

US 6239268

Interleukin-1 type 3 receptors

expired A61KA61K38/00
Status expired
Linked drugs 1
Pipeline programs 6
Years to expiry 0
Applicant portfolio 111
Patent details — US 6239268

Quick answer

US 6239268 (Interleukin-1 type 3 receptors) is held by Neurocrine Biosciences, Inc.. Status: expired. Granted May 29, 2001. Expires May 24, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
13
CPC classes
A61K, A61K38/00

More from Neurocrine Biosciences, Inc.

Related pharmaceutical patents in our USPTO index.

  1. US 12421193

    GPR52 modulators and methods of use

    Neurocrine Biosciences, Inc. · Expires Sep 18, 2045

    granted
  2. US 12383536

    CRF receptor antagonists and methods of use

    Neurocrine Biosciences, Inc. · Expires Aug 7, 2045

    granted
  3. US 12128033

    Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine

    Neurocrine Biosciences, Inc. · Expires Oct 24, 2044

    granted
  4. US 12102637

    Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis

    Neurocrine Biosciences, Inc. · Expires Sep 26, 2044

    granted
  5. US 12083227

    Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis

    Neurocrine Biosciences, Inc. · Expires Sep 5, 2044

    granted
  6. US 11730739

    Treatment of congenital adrenal hyperplasia

    Neurocrine Biosciences, Inc. · Expires Aug 17, 2043

    granted
  7. US 11718618

    Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Expires Aug 3, 2043

    granted
  8. US 11713324

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Expires Jul 27, 2043

    granted

Frequently asked questions

What is US patent 6239268?

US 6239268 (Interleukin-1 type 3 receptors) is held by Neurocrine Biosciences, Inc.. Status: expired. Granted May 29, 2001. Expires May 24, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 6239268?

Neurocrine Biosciences, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 111 pharmaceutical patents for this assignee.

When does US 6239268 expire?

Our index shows an expiration date of May 24, 2021 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.